Astellas Pharma Inc.

About Astellas Pharma Inc

Astellas Pharma Inc is a global pharmaceutical company dedicated to improving the health of people around the world through innovative medicines. Established in 2005, Astellas has its roots in the merger of two Japanese companies, Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. The company focuses on the research, development, manufacturing, and marketing of pharmaceutical products, with a strong emphasis on urology, immunology, oncology, and transplant medicine.

Astellas is committed to addressing unmet medical needs by investing heavily in research and development. The company operates in over 70 countries, with a significant presence in Europe, North America, and Asia. Astellas aims to create value for patients and society by delivering high-quality healthcare solutions.

• Core Values: Innovation, Collaboration, and Integrity.
• Vision: To be a trusted partner in healthcare, enhancing the quality of life for patients.
• Mission: To contribute to the health of people worldwide through the provision of innovative pharmaceuticals.

With a workforce of approximately 17,000 employees globally, Astellas fosters a culture of diversity and inclusion, encouraging collaboration across various disciplines. The company’s commitment to sustainability is evident in its efforts to reduce environmental impact and promote responsible business practices.

Astellas Pharma Inc continues to expand its portfolio through strategic partnerships and acquisitions, ensuring that it remains at the forefront of medical advancements. The company’s dedication to patient-centric approaches drives its research initiatives, aiming to develop therapies that significantly improve patient outcomes.